| pubmed-article:21535161 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21535161 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:21535161 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
| pubmed-article:21535161 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:21535161 | lifeskim:mentions | umls-concept:C1705576 | lld:lifeskim |
| pubmed-article:21535161 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:21535161 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21535161 | pubmed:dateCreated | 2011-7-18 | lld:pubmed |
| pubmed-article:21535161 | pubmed:abstractText | The aim of this retrospective study was to assess the incidence of late complications occurring ?2 years after allogeneic hematopoietic stem cell transplantation (HSCT) for malignant diseases using a T-cell depletion strategy. | lld:pubmed |
| pubmed-article:21535161 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21535161 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21535161 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21535161 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21535161 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21535161 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21535161 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:21535161 | pubmed:issn | 1600-0609 | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:ChapuisBernar... | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:BieriSabineS | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:TrombettiAndr... | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:RoosnekEddyE | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:MiralbellRaym... | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:OzsahinHulyaH | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:HelgClaudineC | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:ChalandonYves... | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:PasswegJakobJ | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:HuguetSaadiaS | lld:pubmed |
| pubmed-article:21535161 | pubmed:author | pubmed-author:AnsariMarcM | lld:pubmed |
| pubmed-article:21535161 | pubmed:copyrightInfo | © 2011 John Wiley & Sons A/S. | lld:pubmed |
| pubmed-article:21535161 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21535161 | pubmed:volume | 87 | lld:pubmed |
| pubmed-article:21535161 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21535161 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21535161 | pubmed:pagination | 138-47 | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:meshHeading | pubmed-meshheading:21535161... | lld:pubmed |
| pubmed-article:21535161 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21535161 | pubmed:articleTitle | Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation. | lld:pubmed |
| pubmed-article:21535161 | pubmed:affiliation | Division of Radiation Oncology, University Hospital, Geneva, Switzerland. | lld:pubmed |
| pubmed-article:21535161 | pubmed:publicationType | Journal Article | lld:pubmed |
